Literature DB >> 17627038

Changes at the CYP2C locus and disruption of CYP2C8/9 linkage disequilibrium in patients with essential tremor.

Carmen Martínez1, Elena García-Martín, Hortensia Alonso-Navarro, Félix Javier Jiménez-Jiménez, Julián Benito-León, Isabel García-Ferrer, Pilar Vázquez-Torres, Inmaculada Puertas, José M Zurdo, Tomás López-Alburquerque, José A G Agúndez.   

Abstract

To identify low-penetrance genes related to sporadic essential tremor (ET) at the CYP2C locus, located in chromosome 10 q23.33. Leukocytary DNA from 200 ET patients and a control group of 300 unrelated healthy individuals with known CYP2C19 genotypes was studied for common CYP2C8 and CYP2C9 allelic variants by using amplification-restriction analyses. Patients with ET showed the following differences compared with healthy subjects: a 1.6-fold reduction in the frequency for CYP2C8*3 (p=0.006), a 1.35-fold reduction of CYP2C9*2 (p=0.05) and a 1.52-fold reduction in the frequency for CYP2C9*3 (p=0.07). The frequency for patients with ET carrying at least one defective allele was 1.33-fold reduced as compared with healthy subjects (p=0.002). In addition, a disruption of the CYP2C8*3/CYP2C9*2 linkage disequilibrium was observed in ET patients, with a 2.1-fold reduction in the percentage for carriers of the haplotype CYP2C8*3 plus CYP2C9*2 in ET patients (p=0.0001). These findings were independent of gender, age, age of onset, or clinical symptoms. These results suggest that alterations at the CYP2C gene locus are associated with the risk for ET.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17627038     DOI: 10.1007/BF02685892

Source DB:  PubMed          Journal:  Neuromolecular Med        ISSN: 1535-1084            Impact factor:   4.103


  45 in total

1.  Population-based case-control study of essential tremor.

Authors:  G Salemi; P Aridon; G Calagna; M Monte; G Savettieri
Journal:  Ital J Neurol Sci       Date:  1998-10

Review 2.  Etiology of essential tremor: should we be searching for environmental causes?

Authors:  E D Louis
Journal:  Mov Disord       Date:  2001-09       Impact factor: 10.338

3.  Epidemiological approaches to the identification of cancer predisposition genes.

Authors:  Timothy R Rebbeck
Journal:  Methods Mol Biol       Date:  2003

Review 4.  Essential tremor.

Authors:  Elan D Louis
Journal:  Lancet Neurol       Date:  2005-02       Impact factor: 44.182

5.  A haplotype map of the human genome.

Authors: 
Journal:  Nature       Date:  2005-10-27       Impact factor: 49.962

Review 6.  Interethnic and intraethnic variability of CYP2C8 and CYP2C9 polymorphisms in healthy individuals.

Authors:  Elena García-Martín; Carmen Martínez; José M Ladero; José A G Agúndez
Journal:  Mol Diagn Ther       Date:  2006       Impact factor: 4.074

7.  Tremor and longevity in relatives of patients with Parkinson's disease, essential tremor, and control subjects.

Authors:  J Jankovic; J Beach; K Schwartz; C Contant
Journal:  Neurology       Date:  1995-04       Impact factor: 9.910

8.  Oxidative metabolism of 5-methoxy-N,N-diisopropyltryptamine (Foxy) by human liver microsomes and recombinant cytochrome P450 enzymes.

Authors:  Shizuo Narimatsu; Rei Yonemoto; Keita Saito; Kazuo Takaya; Takuya Kumamoto; Tsutomu Ishikawa; Masato Asanuma; Masahiko Funada; Kimio Kiryu; Shinsaku Naito; Yuzo Yoshida; Shigeo Yamamoto; Nobumitsu Hanioka
Journal:  Biochem Pharmacol       Date:  2006-02-28       Impact factor: 5.858

9.  Imidacloprid insecticide metabolism: human cytochrome P450 isozymes differ in selectivity for imidazolidine oxidation versus nitroimine reduction.

Authors:  Daniel A Schulz-Jander; John E Casida
Journal:  Toxicol Lett       Date:  2002-06-07       Impact factor: 4.372

10.  Clinical and genetic study of essential tremor in the Italian population.

Authors:  G Abbruzzese; S Pigullo; E Di Maria; P Martinelli; P Barone; R Marchese; C Scaglione; A Assini; C Lucetti; A Berardelli; S Calzetti; E Bellone; F Ajmar; P Mandich
Journal:  Neurol Sci       Date:  2001-02       Impact factor: 3.307

View more
  8 in total

Review 1.  Challenges in essential tremor genetics.

Authors:  L N Clark; E D Louis
Journal:  Rev Neurol (Paris)       Date:  2015-05-21       Impact factor: 2.607

Review 2.  Essential tremor.

Authors:  Lorraine N Clark; Elan D Louis
Journal:  Handb Clin Neurol       Date:  2018

3.  The nonsynonymous Thr105Ile polymorphism of the histamine N-methyltransferase is associated to the risk of developing essential tremor.

Authors:  Maria C Ledesma; Elena García-Martín; Hortensia Alonso-Navarro; Carmen Martínez; Félix Javier Jiménez-Jiménez; Julián Benito-León; Inmaculada Puertas; Lluisa Rubio; Tomás López-Alburquerque; José A G Agúndez
Journal:  Neuromolecular Med       Date:  2008-06-10       Impact factor: 3.843

4.  Vitamin D Receptor and Binding Protein Gene Variants in Patients with Essential Tremor.

Authors:  José A G Agúndez; Elena García-Martín; Hortensia Alonso-Navarro; Christopher Rodríguez; Mónica Díez-Fairén; Ignacio Álvarez; Pau Pastor; Julián Benito-León; Tomás López-Alburquerque; Félix Javier Jiménez-Jiménez
Journal:  Mol Neurobiol       Date:  2022-03-24       Impact factor: 5.590

Review 5.  Genomic Markers for Essential Tremor.

Authors:  Félix Javier Jiménez-Jiménez; Hortensia Alonso-Navarro; Elena García-Martín; Ignacio Álvarez; Pau Pastor; José A G Agúndez
Journal:  Pharmaceuticals (Basel)       Date:  2021-05-27

6.  Analysis of the Functional Polymorphism in the Cytochrome P450 CYP2C8 Gene rs11572080 with Regard to Colorectal Cancer Risk.

Authors:  José M Ladero; José A G Agúndez; Carmen Martínez; Gemma Amo; Pedro Ayuso; Elena García-Martín
Journal:  Front Genet       Date:  2012-12-03       Impact factor: 4.599

Review 7.  Genetic Risk Factors for Essential Tremor: A Review.

Authors:  Vasileios Siokas; Athina-Maria Aloizou; Zisis Tsouris; Ioannis Liampas; Paraskevi Aslanidou; Metaxia Dastamani; Alexandros G Brotis; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  Tremor Other Hyperkinet Mov (N Y)       Date:  2020-06-11

Review 8.  Current and Future Neuropharmacological Options for the Treatment of Essential Tremor.

Authors:  Hortensia Alonso-Navarro; Elena García-Martín; José A G Agúndez; Félix J Jiménez-Jiménez
Journal:  Curr Neuropharmacol       Date:  2020       Impact factor: 7.363

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.